Pharmaceuticals
ISS backs Illumina board; urges rejection of Roche's $6.7-bn bid
07 Apr 2012
ISS says that taking into account the valuation metrics of normal acquisitions, Roche’s offer is inadequate for Illumina whose real potential is the vast end markets in and beyond healthcare
Illumina rejects Roche’s $6.7-bn bid
03 Apr 2012
US-based gene sequencing company Illumina Inc yesterday rejected Swiss drugmaker Roche Holding's increased takeover offer, saying it dramatically undervalued the company
Roche asks Illumina investors to accept its $5.7-bn bid
21 Mar 2012
Swiss drugmaker Roche told Illumina shareholders that its offer price is fair and provides value certainty and liquidity amid increasing headwinds in the gene-sequencing sector
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 Mar 2012
In a surprise move, US drug giant Pfizer Inc, today called off an insulin distribution agreement with Biocon to sell the Bangalore-based company’s biosimilar versions of the drug in key global markets including the US
Natco granted compulsory licence for Bayer's Nexavar
12 Mar 2012
The compulsory licence, the first of its kind to be granted in India, enables Natco to sell the drug at up to Rs8,880 for a pack of 120 tablets against Rs284,428 for Bayer's Nexavar
Asahi Kasei makes $2.2-bn bid for Zoll Medical
12 Mar 2012
Under the deal that has been approved by the board of both companies, Tokyo-based Asahi Kasei will pay $93 per share, a 23.8 per cent premium over the closing price of Zoll on 9 March 2012
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
